April 5, 2016 / 9:57 PM / 2 years ago

TAKE A LOOK-U.S. Treasury Department takes new steps to curb 'inversions'

April 5 (Reuters) - The U.S. Treasury Department took new steps to curb tax-avoiding
corporate "inversions," with the pending $160 billion merger of Pfizer Inc and Allergan
Plc seen as a potential casualty. 
> U.S. Treasury rules put Pfizer-Allergan deal in question                  
> EXCLUSIVE-Pfizer leaning towards abandoning deal with Allergan -source    
> President Obama urges Congress to take action on corporate tax reform     
> Inversion rule fallout hits boutique advisory firms                       
> New U.S. tax-inversion rules weigh on agreed deals                        
> Uncle Sam's anti-inversion hunt may bag big trophy                        
> U.S. Companies doing tax inversions have wide-ranging motives             
> U.S. House Democrats introduce bill to curb company tax inversions        
> U.S. politicians slam tax-avoiding Pfizer-Allergan deal                   
> Pfizer to buy Allergan in $160 billion deal                               

 (Compiled by Americas Desk)
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below